Natco Pharma reports 35% fall in Q2 consolidated net profit

13 Nov 2019 Evaluate

Natco Pharma has reported results for second quarter ended September 30, 2019.

The company has reported 36.72% fall in its net profit at Rs 122.20 crore for the quarter under review as compared to Rs 193.10 crore for the same quarter in the previous year. Total income of the company decreased by 12.54% at Rs 491.60 crore for Q2FY20 as compared Rs 562.10 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 35.19% in its net profit at Rs 117.70 crore for the quarter under review as compared to Rs 181.60 crore for the same quarter in the previous year. Total income of the company decreased by 11.07% at Rs 518.90 crore for Q2FY20 as compared Rs 583.50 crore for the corresponding quarter previous year.

Natco Pharma Share Price

1032.30 3.10 (0.30%)
28-May-2024 15:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.